Literature DB >> 21111716

Neuroprotective effects of magnesium-sulfate on ischemic injury mediated by modulating the release of glutamate and reduced of hyperreperfusion.

Sung Wook Kang1, Seok-Keun Choi, Eunkuk Park, Su-Jin Chae, Samjin Choi, Hyo Jin Joo, Gi-Ja Lee, Hun-Kuk Park.   

Abstract

This study examined the neuroprotective effects of magnesium-sulfate (MgSO(4)) on the cerebral blood flow (CBF) and extracellular glutamate concentration in an eleven vessel occlusion (11VO) rat model. Twenty-one male Sprague-Dawley rats (250-350g) were used for the 11VO ischemic model, which was induced by a 10-min transient occlusion. The animals were divided into 3 groups, including ischemic-induced animals (ischemia group), ischemic-induced and MgSO(4) treated animals (MgSO(4) group), and sham animals for comparison. The real-time extracellular glutamate concentration was measured using a microdialysis biosensor, and the CBF was monitored by laser Doppler flowmetry. Neuronal cell death in the hippocampal region was observed 72h after ischemia by several stains (Nissl, DAPI, NeuN, and cleaved caspase3). A significant decrease in %CBF was observed in both the ischemia and MgSO(4) groups, such as ~10% during the ischemic period. However, the MgSO(4) group showed a significant decrease in the initial reperfusion %CBF compared to the ischemia group. A significantly lower level of glutamate release was observed in the MgSO(4) group than in the ischemia group during the ischemic and reperfusion episode. Our staining results revealed a significant decrease in neuronal cell death in the hippocampus in the MgSO(4) group compared to the ischemia group. These results suggest that MgSO(4) is responsible for the protection of neuronal cells by suppressing the release of extracellular glutamate under ischemic conditions and the CBF response during the initial reperfusion period. Copyright Â
© 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21111716     DOI: 10.1016/j.brainres.2010.11.057

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

1.  Differential Gene Expression in Cord Blood of Infants Diagnosed with Cerebral Palsy: A Pilot Analysis of the Beneficial Effects of Antenatal Magnesium Cohort.

Authors:  Maria L V Dizon; Raye-Ann O deRegnier; Steven J Weiner; Michael W Varner; Dwight J Rouse; Maged M Costantine; Ronald J Wapner; John M Thorp; Sean C Blackwell; Nina K Ayala; Antonio F Saad; Steve N Caritis
Journal:  Dev Neurosci       Date:  2022-06-15       Impact factor: 3.421

2.  MMP-9 inhibitor SB-3CT attenuates behavioral impairments and hippocampal loss after traumatic brain injury in rat.

Authors:  Feng Jia; Yu Hua Yin; Guo Yi Gao; Yu Wang; Lian Cen; Ji-Yao Jiang
Journal:  J Neurotrauma       Date:  2014-06-03       Impact factor: 5.269

3.  Concussions: What a neurosurgeon should know about current scientific evidence and management strategies.

Authors:  Matthew T Neal; Jonathan L Wilson; Wesley Hsu; Alexander K Powers
Journal:  Surg Neurol Int       Date:  2012-02-15

4.  Evaluation of the anti-inflammatory effects of peri-operative infusion of magnesium sulfate on the microsurgical procedures for intracranial tumors.

Authors:  Farhad Etezadi; Majid Aklamli; Atabak Najafi; Mohammadreza Khajavi; Reza Shariat Moharari; Bahador Mirrahimi; Seyed Abolghasem Mortazavi; Mojtaba Mojtahedzadeh
Journal:  Anesth Pain Med       Date:  2014-11-30

Review 5.  Magnesium sulfate and fetal neuroprotection: overview of clinical evidence.

Authors:  Clément Chollat; Stéphane Marret
Journal:  Neural Regen Res       Date:  2018-12       Impact factor: 5.135

Review 6.  Fetal Neuroprotective Strategies: Therapeutic Agents and Their Underlying Synaptic Pathways.

Authors:  Nada A Elsayed; Theresa M Boyer; Irina Burd
Journal:  Front Synaptic Neurosci       Date:  2021-06-23

7.  The effects of levosimendan on brain metabolism during initial recovery from global transient ischaemia/hypoxia.

Authors:  Anna B Roehl; Norbert Zoremba; Markus Kipp; Johannes Schiefer; Andreas Goetzenich; Christian Bleilevens; Nikolaus Kuehn-Velten; Rene Tolba; Rolf Rossaint; Marc Hein
Journal:  BMC Neurol       Date:  2012-08-24       Impact factor: 2.474

8.  Levosimendan limits reperfusion injury in a rat middle cerebral artery occlusion (MCAO) model.

Authors:  Marc Hein; Norbert Zoremba; Chistian Bleilevens; Christian Bruells; Rolf Rossaint; Anna B Roehl
Journal:  BMC Neurol       Date:  2013-08-12       Impact factor: 2.474

9.  Neuroprotective therapies after perinatal hypoxic-ischemic brain injury.

Authors:  Felipe Goñi de Cerio; Idoia Lara-Celador; Antonia Alvarez; Enrique Hilario
Journal:  Brain Sci       Date:  2013-03-05

Review 10.  Fetal Neuroprotection by Magnesium Sulfate: From Translational Research to Clinical Application.

Authors:  Clément Chollat; Loïc Sentilhes; Stéphane Marret
Journal:  Front Neurol       Date:  2018-04-16       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.